UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer

PloS one, 2022-12, Vol.17 (12), p.e0278711-e0278711

2022

Volltextzugriff (PDF)

Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid

PloS one, 2014-03, Vol.9 (3), p.e89919

2014

Volltextzugriff (PDF)

Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer

PloS one, 2022-12, Vol.17 (12)

2022

Volltextzugriff (PDF)

Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells

AAPS PharmSciTech, 2019-03, Vol.20 (3), p.135, Article 135

2019

Volltextzugriff (PDF)

Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer

Cancers, 2023-09, Vol.15 (17), p.4356

2023

Volltextzugriff (PDF)

Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells

Journal of cellular biochemistry, 2013-07, Vol.114 (7), p.1575-1583

2013

Volltextzugriff (PDF)

Mass spectrometry database of lacrimal gland adenoid cystic carcinoma and normal lacrimal gland tissue identifies extracellular matrix remodeling in these tumors

Data in brief, 2023-08, Vol.49, p.109330-109330, Article 109330

2023

Volltextzugriff (PDF)

Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)

Colloids and surfaces, B, Biointerfaces, 2017-05, Vol.153, p.208-219

2017

Volltextzugriff (PDF)

Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1)

PloS one, 2013-08, Vol.8 (8), p.e69519

2013

Volltextzugriff (PDF)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

Scientific reports, 2017-11, Vol.7 (1), p.15824-11, Article 15824

2017

Volltextzugriff (PDF)

Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer

Molecular pharmaceutics, 2016-06, Vol.13 (6), p.2049-2058

2016

Volltextzugriff (PDF)

Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer

Experimental cell research, 2016-08, Vol.346 (1), p.65-73

2016

Volltextzugriff (PDF)

NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration

Molecular and cellular biology, 2016-05, Vol.36 (9), p.1383-1394

2016

Volltextzugriff (PDF)

Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer

Drug delivery, 2016-05, Vol.23 (4), p.1232-1241

2016

Volltextzugriff (PDF)

Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer

Pharmaceutical research, 2017-11, Vol.34 (11), p.2371-2384

2017

Volltextzugriff (PDF)

Abstract 3832: Synergistic anticancer effects of epigenetic drugs JQ1 and SAHA in adenoid cystic carcinoma of the lacrimal gland

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3832-3832

2019

Volltextzugriff (PDF)

Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer

European journal of pharmaceutics and biopharmaceutics, 2016-11, Vol.108, p.168-179

2016

Volltextzugriff (PDF)

Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment

Journal of controlled release, 2017-01, Vol.246, p.120-132

2017

Volltextzugriff (PDF)

Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy

Endocrine-related cancer, 2015-10, Vol.22 (5), p.831-840

2015

Volltextzugriff (PDF)

Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma

Pharmaceutical research, 2016-01, Vol.33 (1), p.137-154

2016

Volltextzugriff (PDF)

Abstract 4833: CDODA-Me augments the efficacy of chemotherapeutic agents and overcomes chemo-resistance in breast and lung cancer cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4833-4833

2016

Volltextzugriff (PDF)

Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models

Journal of controlled release, 2013-11, Vol.172 (1), p.86-95

2013

Volltextzugriff (PDF)

Abstract 2619: Synergistic anticancer effect of Noscapine and Camptothecin is mediated through apoptosis and cell cycle arrest in A549 lung cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2619-2619

2015

Volltextzugriff (PDF)

Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer

Journal of pharmaceutical sciences, 2015-12, Vol.104 (12), p.4417-4426

2015

Volltextzugriff (PDF)

Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer

AAPS PharmSciTech, 2018-02, Vol.19 (2), p.792-802

2018

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(32)
Humans
(26)
Animals
(20)
Female
(19)
Cell Line, Tumor
(15)
Mice
(12)
Pharmacology & Pharmacy
(12)
Mice, Nude
(10)
Antineoplastic Agents - Pharmacology
(9)
Chemistry
(9)
Physical Sciences
(9)
Science & Technology - Other Topics
(9)
Antineoplastic Agents - Administration & Dosage
(8)
Apoptosis
(8)
Biological Availability
(7)
Biotechnology & Applied Microbiology
(6)
Chemistry, Multidisciplinary
(6)
Multidisciplinary Sciences
(6)
Pharmacy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(7)
Cancer Research
(6)
Journal Of Controlled Release
(3)
Aaps Pharmscitech
(2)
Clinica Chimica Acta
(2)
Colloids And Surfaces, B, Biointerfaces
(2)
Drug Delivery
(2)
Molecular And Cellular Biology
(2)
Nanomedicine
(2)
Oncotarget
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer

Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid

Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer

Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells

Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer

Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells

Mass spectrometry database of lacrimal gland adenoid cystic carcinoma and normal lacrimal gland tissue identifies extracellular matrix remodeling in these tumors

Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)

Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer

Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer

NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration

Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer

Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer

Abstract 3832: Synergistic anticancer effects of epigenetic drugs JQ1 and SAHA in adenoid cystic carcinoma of the lacrimal gland

Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer

Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment

Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy

Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma

Abstract 4833: CDODA-Me augments the efficacy of chemotherapeutic agents and overcomes chemo-resistance in breast and lung cancer cells

Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models

Abstract 2619: Synergistic anticancer effect of Noscapine and Camptothecin is mediated through apoptosis and cell cycle arrest in A549 lung cancer

Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer

Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer

Suchergebnisse filtern